GSK opens Spain’s first maximum biosecurity laboratory 20/03/2026 Healthcare Innovative drugs Spain Prime Minister, Pedro Sánchez, recently visited the first maximum biosafety level (BSL-4) laboratory in Spain... Partners - GSK
AseBio promotes in Brussels the vision of the Spanish biotechnology sector on the Biotech ... 23/03/2026 Healthcare Rare diseases Innovative drugs Advanced therapies EU projects Our Director General, Ion Arocena, participated in the latest meeting of the MEP Interest Group “EU Biotech and Life... AseBio
Promising results for GAT Therapeutics drug in development for pulmonary fibrosis 16/03/2026 Healthcare The biotech company GAT Therapeutics, based at the University of Barcelona Parc Científic de Barcelona (PCB-UB), is... Partners - Parc Científic de Barcelona
GENESIS Biomed sponsors the 4th Conference on Healthcare Entrepreneurship at the Gregorio ... 13/03/2026 Healthcare The conference was organised by the UAI (Innovation Support Unit) of the IiSGM (Gregorio Marañón Health Research... Partners - GENESIS Biomed
ORYZON expands patent protection for iadademstat with grant decision in Mexico covering co... 12/03/2026 Healthcare Advanced therapies Industrial biotechnology Key combination for the treatment of Small Cell Lung Cancer. Partners - Oryzon Genomics
Diana Morant, Minister for Science, Innovation and Universities: “Biotechnology is a strat... 10/03/2026 Healthcare Agrifood Industrial biotechnology Financing The Spanish Bioindustry Association (AseBio) has organized a conference at the Ministry of Science that brought together... AseBio
Diana Morant, Minister for Science, Innovation and Universities: “Biotechnology is a strat... 10/03/2026 The Spanish Bioindustry Association (AseBio) has organized a conference at the Ministry of Science that brought together... AseBio
Illumina launches TruPath Genome, setting a new standard in genomic insight 04/03/2026 Healthcare TruPath™ Genome offers more complete genome, with the simplest sample to sequencer workflow. Data presented at AGBT... Partners - Illumina
Sequencing to diagnose earlier: how biotechnology can help short the rare diseases diagnos... 28/02/2026 Healthcare Rare diseases In a context in which most of these pathologies have a genetic origin, tools such as whole genome sequencing (WGS) are... Partners - Illumina
ORYZON reports financial results and corporate update for quarter ended December 31st, 202... 02/03/2026 Healthcare Innovative drugs Personalized medicine Advanced therapies Financing Strong cash position at year-end 2025: $33.3 million (€28.4 million). Partners - Oryzon Genomics
